Recalcitrant, recurrent aphthous stomatitis successfully treated with adalimumab

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 2, 2009, Pages 206-

  Sanchez Cano D ^a   Callejas Rubio, J L ^a   Ruiz Villaverde, R ^b   Ortego Centeno, N ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b Hosp Univ Ciudad de Jaén   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; METHYLPREDNISOLONE;

ABSENCE OF SIDE EFFECTS; ADULT; ANAMNESIS; APHTHOUS STOMATITIS; CASE REPORT; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; LABORATORY TEST; LETTER; MALE; ORAL BIOPSY; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

EID: 58449104116     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02790.x     Document Type: Letter

References (4)

1. Altenburg A, Abdel-Naser MB, Seeber H, Abdallah M, Zouboulis CC. Practical aspects of management of recurrent aphthous stomatitis. J Eur Acad Dermatol Venereol 2007 21 : 1019 1026.
2. Buño IJ, Huff JC, Weston WL, Cook DT, Brice SL. Elevated levels of interferon gamma, tumor necrosis factor alpha, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis. Arch Dermatol 1998 134 : 827 831.
3. Vujevich J, Zirwas M. Treatment of severe, recalcitrant, major aphthous stomatitis with adalimumab. Cutis 2005 76 : 129 132.
4. Robinson ND, Guitart J. Recalcitrant, recurrent aphthous stomatitis treated with etanercept. Arch Dermatol 2003 139 : 1259 1262.